We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
[Prescribing drugs by international non-proprietary name: the perception of health and non-health professionals].
Thérapie 2005 July
AIM: The aim of this study was to evaluate the perceptions of health professionals and non-health professionals with regard to prescribing drugs by their international non-proprietary name (INN) in the Midi-Pyrénées area, France.
METHODS: We developed a score to assess the perception of the four criteria that make up therapeutic progress: efficacy, safety, convenience and cost for the National Health Insurance. Changes in perception under these criteria were scored between 0 and 10 (0 for no change and 10 for maximal change). The questionnaire was answered by 142 general practitioners, 161 pharmacists and 132 healthy subjects (public).
RESULTS: The median value (first quartile to third quartile) for the perceived change in efficacy was 0 (0-3) for physicians and pharmacists, and 0 (0-0) for the public. The median value for the perceived change in safety was 0 (0-3) for practitioners and pharmacists, and 0 (0-5) for the public. The median value for the perceived change in convenience was 0 (0-6) for practitioners, 5 (0-6) for pharmacists and 0 (0-0) for the public. The median value for the perceived change in cost was 6 (3-8) for practitioners, 8 (5-10) for pharmacists and 10 (6-10) for the public.
CONCLUSION: This study shows that there is generally favourable acceptance of prescribing by INN by those in the health area. However, general practitioners seem to be more reluctant to accept this than pharmacists or the general public.
METHODS: We developed a score to assess the perception of the four criteria that make up therapeutic progress: efficacy, safety, convenience and cost for the National Health Insurance. Changes in perception under these criteria were scored between 0 and 10 (0 for no change and 10 for maximal change). The questionnaire was answered by 142 general practitioners, 161 pharmacists and 132 healthy subjects (public).
RESULTS: The median value (first quartile to third quartile) for the perceived change in efficacy was 0 (0-3) for physicians and pharmacists, and 0 (0-0) for the public. The median value for the perceived change in safety was 0 (0-3) for practitioners and pharmacists, and 0 (0-5) for the public. The median value for the perceived change in convenience was 0 (0-6) for practitioners, 5 (0-6) for pharmacists and 0 (0-0) for the public. The median value for the perceived change in cost was 6 (3-8) for practitioners, 8 (5-10) for pharmacists and 10 (6-10) for the public.
CONCLUSION: This study shows that there is generally favourable acceptance of prescribing by INN by those in the health area. However, general practitioners seem to be more reluctant to accept this than pharmacists or the general public.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app